Research Article: Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Introduction:
Primary liver cancer is the sixth most common cancer and the third leading cause of cancer death in the world, and hepatocellular carcinoma (HCC) accounts for %-%. Since approximately half of HCC patients are diagnosed at an advanced stage, the -year survival rate is only %. , In recent years, studies on the treatment of advanced HCC have emerged one after another, with studies on interventional therapy combined with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), which was referred to…
Read more